20247 ⎘
Medicinal preparations containing organic active ingredients; Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids; Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
CYCLODEXTRIN COMPLEXES OF SPECIALIZED PRORESOLVING MEDIATORS
#2Nutritional composition for neurodegeneration and neurotrauma
#3KIT TO PROMOTE DEVELOPMENTAL MYELINATION
#4COMPOSITION FOR ENHANCING ADRENOMEDULLIN GENE EXPRESSION
#5HIGHLY PURIFIED (R)-3’-HYDROXYBUTYL (R)-3’-HYDROXYBUTYRATE AND (R)-3-HYDROXYBUTYRATE AND COMBINATIONS WITH THERAPEUTICS
#6LIPID COMPRISING DOCOSAPENTAENOIC
#7ANTIMICROBIAL COMPOSITIONS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF
#8INFLAMMATORY DISORDER IN A FELIDAE
#9Dietary Pattern Directed Nutritional Supplementation Composition and Methods for Attenuating Age-Related Cognitive Decline or Enhancing Cognitive Function
#10METHOD FOR INCREASING POLLINATION IN CROPS SUSCEPTIBLE TO POLLINATION OF INVERTEBRATES OF THE APIDEAE FAMILIES
#11NEURAL REPAIR COMPOSITION, METHOD OF PREPARATION, AND USE THEREOF
#12PIPERIDINE UREA DERIVATIVES FOR CANCER THERAPY
#13COMPOSITION OR ASSOCIATION OF COMPOUNDS PREFERABLY FOR USE IN THE TREATMENT OF NERVOUS DISEASES IN PARTICULAR NEURODEGENERATIVE DISEASES, METHOD FOR THE PREPARATION OF SUCH COMPOSITION OR ASSOCIATION OF COMPOUNDS AND USES THEREOF
#14SYNTHESIS OF PRO-RESOLVING ANALOGS AND COMPOSITIONS THEREFOR
#15COMPOSITIONS FOR AND METHODS TO TREAT, PREVENT, OR REVERSE METABOLIC SYNDROME, TYPE 2 DIABETES, AND/OR CARDIOVASCULAR DISEASE
#16THRAUSTOCHYTRIDS, FATTY ACID COMPOSITIONS, AND METHODS OF MAKING AND USES THEREOF
#17Composition for regulation of autonomic nervous system
#18METHODS FOR IMPROVING COGNITIVE FUNCTION
#19PARENTERAL NUTRITION FORMULATION
#20Compositions and Methods for Treating Cardiovascular Diseases and Disorders
#21DIETARY SUPPLEMENT FORMULATION AND METHOD OF PREPARATION THEREOF
#22Heart boosting formulation and related methods of manufacture
#23COMPOSITION AND USE OF SAME FOR CONTROLLING INFECTIONS IN AQUATIC ORGANISMS
#24Core four dietary supplement system
#25Compositions and Methods for Treating Endocrine Diseases and Disorders
#26STABILIZED MICROCAPSULES, METHOD OF THEIR PREPARATION AND USES THEREOF
#27CORDYLUTENES WITH EXTRAORDINARY EFFECT IN BLUE LIGHT ABSORPTION
#28CETOLEIC ACID COMPOSITION
#29METHODS OF INCREASING MESENCHYMAL STROMAL CELL BIOSYNTHESIS OF SPECIALIZED PRO-RESOLVING MEDIATORS AND METHODS OF USE
#30METHODS OF REDUCING THE RISK OF CARDIOVASCULAR EVENTS IN A SUBJECT WITH ATRIAL FIBRILLATION AND/OR ATRIAL FLUTTER
#31ALPHA POLYGLUTAMATED TETRAHYDROFOLATES AND USES THEREOF
#32ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS
#33Pet Food Compositions Comprising Caprylic Acid And Docosahexaenoic Acid And/Or Eicosapetaenoic Acid For Use In Treating Struvite Urolithiasis
#34ORODISPERSIBLE TABLET, IN PARTICULAR FOR USE AS A FOOD SUPPLEMENT
#35SYSTEMS FOR GENERATING PERSONALIZED DIETARY SUPPLEMENTS
#36Antiviral Composition for Animals
#37Nutritional composition for stroke
#38VERY LONG CHAIN FATTY ACIDS FOR TREATMENT AND ALLEVIATION OF DISEASES
#39CAROTENOID COMPOSITIONS AND USES THEREOF
#40COMPOUNDS, COMPOSITIONS, AND METHODS FOR REDUCING PRODUCTION OF TRIMETHYLAMINE
#41PROCESSES FOR PRODUCING LOW CHLOROPHYLL, HIGH POLAR LIPID COMPOSITIONS FROM ALGAL OILS AND EXTRACTS
#42STRUCTURALLY MODIFIED FATTY ACIDS FOR IMPROVING GLYCEMIC CONTROL AND TREATING INFLAMMATORY BOWEL DISEASE
#43Herbal composition for use in the improvement of physical and mental health recovery and maintenance, including the improvement of cognitive function or prevention of cognitive decline
#44Nutraceutical Composition for Multimodal Prophylaxis
#45FLAVONOID-CONTAINING COMPOSITIONS AND TREATMENT OF VIRAL DISEASES WITH SAME
#46COMPOSITIONS AND METHODS FOR TREATING HEARING AND OCULAR DISORDERS
#47FORMULATIONS FOR IMPROVING GUT HEALTH
#48COMPOSITION AND APPLICATION THEREOF
#49FATTY ACID COMPOUNDS
#50COMPOSITION FOR PREVENTING AND/OR TREATING A PATHOLOGICAL DYSBIOSIS OF THE INTESTINAL MICROBIOTIA
#51NUTRITIONAL COMPOSITION FOR IMPROVING GUT MICROBIOTA
#52COMPOSITIONS COMPRISING ENCAPSULATED TRETINOIN
#53COMPOSITIONS FOR USE
#54TOPICAL FORMULATION COMPRISING OMEGA-3 FATTY ACIDS, MELATONIN AND VITAMIN D
#55CANCER-KILLING CELLS
#56Neurodegenerative Disorders And Muscle Diseases Implicating Pufas
#57TREATMENT WITH HIGHLY PURIFIED EICOSAPENT AENOIC ACID AS FREE FATTY ACID IMPROVES INFLAMMATION, AFFECTS COLONIC DIFFERENTIATION MARKERS AND MICROBIOTA IN PATIENTS WITH ULCERATIVE COLITIS
#58FORMULATIONS AND COMPOSITIONS FOR ORTHO- AND/OR RETRO-NASAL DELIVERY AND ASSOCIATED SYSTEMS, METHODS AND ARTICLES
#59PHARMACEUTICAL COMPOSITION FOR TREATMENT OF HEART FAILURE WITH DIASTOLIC DYSFUNCTION
#60SYNTHETIC PROCESS FOR PRODUCTION OF LIPOXIN B4 AND ANALOGUES THEREOF
#61Methods and Compositions for Oral Administration of Proteins
#62Fish Oil Traditional Chinese Medicine Complex with Comprehensive Blood Lipid Regulating Effect and Preparation Method and Application thereof
#63COMPOSITIONS COMPRISING 15-HEPE AND METHODS OF USING THE SAME
#64COMPOSITIONS FOR SUPPLEMENTING PRODUCTS WITH THERAPEUTIC AGENTS AND METHODS OF USE THEREOF
#65COMPOSITIONS AND THEIR USE
#66PRENATAL SUPPLEMENT
#67FATTY ACID COMPOSITIONS
#68Pectin Gel and Preparation Method Thereof
#69DIETARY NUTRIENT COMPOSITIONS
#70SPECIALIZED PRO-RESOLVING LIPID MEDIATORS FOR TREATING LONG COVID-19
#71Long-term efficacy of liver disease treatment with EPA and DHA
#72Deuterated Polyunsaturated Fatty Acids Or Esters Thereof For Cosmetic Applications
#73HIGHLY UNSATURATED FATTY ACID OR HIGHLY UNSATURATED FATTY ACID ETHYL ESTER WITH REDUCED ENVIRONMENTAL POLLUTANTS, AND METHOD FOR PRODUCING SAME
#74Pharmaceutical Compositions of D10-Docosahexaenoic Acid or Esters Thereof
#75DODECA-2,4,6,8,10-PENTAENOIC ACID COMPOSITIONS AND USES THEREOF
#76VERY-LONG-CHAIN POLYUNSATURATED FATTY ACIDS (VLCPUFA) FOR IMPROVING RETINA/COGNITIVE FUNCTIONS AND ATHEROSCLEROSIS
#77COMPOSITIONS AND METHODS FOR PROVIDING A HEALTH BENEFIT TO A GROWING ANIMAL
#78COMPOSITIONS FOR USE
#79COMPOSITIONS FOR USE
#80COMPOSITION FOR PREVENTING AND TREATING STROKE COMPRISING EXTRACT OF JUGLANS MANDSHURICA FRUIT
#81Dietary fiber for treating patients suffering from methylmalonic acidemia and propionic acidemia
#82TRANS-VACCENIC ACID (TVA) AND DERIVATIVES THEREOF IN T CELL-BASED CANCER THERAPIES
#83METHODS FOR TREATING A CORONAVIRUS INFECTION USING VALPROIC ACID AND DOCOSAHEXAENOIC ACID
#84PHARMACEUTICAL COMPOSITION CONTAINING VITAMIN K2 FOR IMPROVING CARDIOVASCULAR CALCIFICATION, PREPARATION METHOD THEREFOR AND USE THEREOF
#85Compositions and Methods for Treating Neurodegenerative Diseases and Disorders
#86Compositions and Methods for Treating Cardiovascular Diseases and Disorders
#87Methods And Kits For Reducing Microplastics Levels And/Or Reducing Or Minimizing Microplastics Accumulation Rates In Subjects
#88USE OF A COMPOSITION FOR MANAGING POSTPRANDIAL GLUCOSE RESPONSE AND ASSOCIATED DISORDERS
#89ALPHA POLYGLUTAMATED LOMETREXOL AND USES THEREOF
#90Prophylactic Methods For Treating ALS
#91PHARMACEUTICAL COMPOSITION FOR IMPROVING LIFE QUALITY OF ELDERLY PEOPLE ON BASIS OF VITAMIN K2, PREPARATION METHOD THEREFOR AND USE THEREOF
#92PLANT-BASED COMPOSITIONS AND METHODS FOR HORMONE SIGNALING, BLOOD GLUCOSE CONTROL, APPETITE CONTROL, AND WEIGHT MANAGEMENT
#93Pharmaceutical Composition for Postpartum Recovery and Treatment of Pelvic Floor Dysfunction
#94LIPID FORMULATIONS CONTAINING BIOACTIVE FATTY ACIDS AND OTHER BIOACTIVE AGENTS
#95HEALING CREAMS AND FORMULATIONS CONTAINING POMEGRANATE SEED OIL, ROSA CANINA FRUIT OIL, INULA VISCOSA OLEORESIN OR EXTRACT AND OPTIONALLY CITRUS MEDICA VULGARIS ETROG OIL OR EXTRACT
#96COMPOSITIONS COMPRISING 15-OHEPA AND METHODS OF USING THE SAME
#97Methods for Treating Tauopathy
#98COMPOSITION COMPRISING A MIXTURE OF DHA AND/OR EPA AND A PHOSPHOLIPID OF PLANT ORIGIN
#99METHODS OF TREATING MIXED DYSLIPIDEMIA
#100Composition for Prevention and Treatment of Bacterial and Viral Infections and Inflammation
#101OLEOGEL AND PREPARATION METHOD THEREFOR AND USE THEREOF
#102METHODS, COMPOSITIONS, AND DEVICES FOR SUPPLYING DIETARY FATTY ACID NEEDS
#103RADIOPAQUE INK FORMULATION
#104METHOD OF GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE (GIP) STABILIZATION
#105NOVEL COMPOSITIONS FOR PROMOTING EYE HEALTH OF A COMPANION ANIMAL
#106Combination therapy of omega-3, black cumin, manuka honey, Anise, Vitamin-D, Nutmeg in treating COVID-19
#107SUNFLOWER SEED COMPOSITION RICH IN PLEASANT PROHORMONE AND ANTI-DEPRESSION APPLICATION THEREOF
#108COMPOSITION AND METHODS FOR MODULATION OF ELOVL2
#109COMPOSITION FOR IMPROVING IMMUNITY OF COMPANION ANIMALS
#110Methods for Inhibiting the Progression of Oxidative Retinal Disease
#111SYSTEMS AND METHODS FOR THROMBOSIS PREVENTION
#112LYSOPHOSPHATIDYLCHOLINE COMPOSITIONS
#113ALPHA POLYGLUTAMATED METHOTREXATE AND USES THEREOF
#114GLYCOGEN OR POLYSACCHARIDE STORAGE DISEASE TREATMENT METHOD
#115Methods and Compositions for Treatment of Inflammatory Disease
#116RXR AGONISTS IN EYE DISORDERS
#117HIGHLY PURIFIED EICOSAPENTAENOIC ACID, AS FREE FATTY ACID, REDUCES FECAL CALPROTECTIN LEVELS AND PREVENTS CLINICAL RELAPSE IN ULCERATIVE COLITIS PATIENTS
#118METHODS AND COMPOSITIONS FOR TREATING AGING AND CHRONIC DISEASE
#119PHOSPHOLIPID COMPOSITIONS FOR DELIVERY OF THERAPEUTIC COMPOUNDS
#120Anti-Inflammatory Methods with Compositions Comprising Site-Specific Isotopically-Modified Fatty Acids
#121COMPOSITION FOR PROMOTING THE MATURING OF THE CENTRAL NERVOUS SYSTEM
#122Methods for Treating Neurological Disorders Using Nutrient Compositions
#123COMPOSITIONS AND METHODS FOR DIAGNOSING AND/OR TREATING CHRONIC KIDNEY DISEASE
#124METHOD FOR ALLEVIATING OXIDATIVE STRESS
#125A SELF-EMULSIFYING DRUG DELIVERY SYSTEM (SEDDS) OF PUNICIC ACID COMBINED WITH NEUROPROTECTIVE NATURAL PRODUCTS TO DELAY ONSET, PREVENT, OR REVERSE NEURODEGENERATIVE DISEASE
#126COMPOSITIONS AND METHODS OF TREATING CANCER USING LIPID AGONISTS AND RECEPTORS THEREOF
#127COMPOSITIONS COMPRISING 15-HEPE AND METHODS OF TREATING OR PREVENTING HEMATOLOGIC DISORDERS, AND/OR RELATED DISEASES
#128COMPOSITIONS HAVING HIGH LEVELS OF DPA (n-3) AND METHODS FOR PRODUCING
#129LIPID EMULSIONS FOR PARENTERAL NUTRITION
#130COMPOSITIONS AND METHODS USING A COMBINATION OF NUTRIENTS TO SUPPORT COGNITION AND EMOTIONAL HEALTH IN A MAMMAL
#131LIPID EMULSIONS FOR PARENTERAL NUTRITION
#132FREE-POLYUNSATURATED-FATTY-ACID-CONTAINING COMPOSITION AND METHOD FOR MANUFACTURING SAME
#133COMPOSITIONS AND METHODS FOR TARGETING GPCR FOR THE PREVENTION AND TREATMENT OF PAIN
#134Fatty acid compositions
#135COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF INFLAMMATORY, DEGENERATIVE, AND NEURODEGENERATIVE DISEASES
#136CYCLODEXTRIN COMPLEXES OF SPECIALIZED PRORESOLVING MEDIATORS
#137NUTRITIONAL COMPOSITION FOR IMPROVING SLEEP
#138AGENT FOR PREVENTING, TREATING, OR IMPROVING INFLAMMATORY SKIN DISEASE
#139COMPOSITION AND METHODS OF TREATMENT USING SYNERGISTICALLY - ENHANCED SUPPLEMENTATION
#140Combination methods and compositions including sleep therapeutics for treating mood
#141ANTI-ALLERGIC AGENT
#142NUTRITIONAL COMPOSITIONS
#143DERIVATIVES OF THE PROTECTIN 10S,17S-DIHDA (PDX) AND USE THEREOF AS ANTIVIRAL, ANTI-INFLAMMATORY, AND ANTI-DIABETIC AGENTS
#144SYNERGISTIC COMBINATION THERAPY FOR TREATING ALS
#145METHODS OF ADJUVANT THERAPY
#146LIPID EMULSION FOR PARENTERAL NUTRITION COMPRISING GPC
#147CANNABINOID-HUMIC SUBSTANCES COMPOSITION AND MEHTHOD OF MAKING THE SAME
#148USE OF H3K9me3 MODULATION FOR ENHANCING COGNITIVE FUNCTION
#149METHODS AND COMPOSITIONS FOR TREATING SEPSIS
#150ORAL ALGAL OIL BASED GASTRO-INTESTINAL TRACT PERMEABLE PEPTIDE COMPOSITION
#151USE OF CISTANCHE TUBULOSA EXTRACT IN THE PREPARATION OF A MEDICAMENT FOR RELIEVING DRY EYE SYNDROME
#152SOLID SOLUBLE COMPOUND FOR APPLICATION AS A CARRIER OF ACTIVE AGENTS OR MULTIFUNCTIONAL COATING ON PLANT AND FRUIT STRUCTURES AND METHOD OF OBTAINMENT THEREOF
#153Nutritional Composition
#154DELIVERY METHODS FOR TREATING BRAIN AND CENTRAL NERVOUS SYSTEM DISEASES
#155CAROTENOID SOLUTIONS AND USES THEREOF
#156EYE HEALTH SUPPLEMENT WITH CURCUMIN
#157FORMULATIONS AND COMPOSITIONS FOR ORTHO- AND/OR RETRO-NASAL DELIVERY AND ASSOCIATED SYSTEMS, METHODS AND ARTICLES
#158METHODS, COMPOSITIONS, AND DEVICES FOR SUPPLYING DIETARY FATTY ACID NEEDS
#159METHODS, COMPOSITIONS, AND DEVICES FOR SUPPLYING DIETARY FATTY ACID NEEDS
#160NUTRITIONAL COMPOSITION AND INFANT FORMULA FOR PROMOTING DE NOVO MYELINATION
#161PERINAPHTHENONE COMPOUND AND USE THEREOF
#162TARGETING SELECT LIPID SIGNALING TO COUNTER TYPE 1 DIABETES (T1D)
#163COMPOSITIONS AND METHODS FOR MODULATING EQUINE FATTY ACID PROFILES
#164COMBINATION THERAPIES COMPRISING OXYGEN-CONTAINING STRUCTURALLY ENHANCED FATTY ACIDS FOR TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS
#165REAGENTS AND METHODS FOR PROMOTING ARTERIAL ENDOTHELIUM DIFFERENTIATION AND NITRIC OXIDE PRODUCTION
#166Solid composition suitable as a nutritional composition or supplement for animals that suffer from brain related disorders, decline or diseases
#167METHODS OF TREATMENT
#168NOVEL OMEGA 3 CARRIER PREPARATIONS FOR INHALATION DRUG DELIVERY FOR TREATING LUNG INFLAMMATION
#169CRYSTALLINE FORMS OF A DIFFUSION ENHANCING COMPOUND
#170COMPOSITIONS COMPRISING 15-HEPE AND METHODS OF TREATING AND/OR PREVENTING HEMATOLOGIC DISORDERS AND RELATED DISEASES
#171BCMA Monoclonal Antibody-Drug Conjugate
#172NUTRITIONAL COMPOSITIONS WITH MFGM AND CERTAIN HUMAN MILK OLIGOSACCHARIES AND USES THEREOF
#173METHODS FOR DECREASING INJURIES ASSOCIATED WITH INTRAOPERATIVE HYPOTENSION
#174COMPOSITIONS AND METHODS FOR TREATING DEPRESSION
#175RESPIRATORY TREATMENTS USING SALMONID OIL COMPOSITIONS
#176METHODS OF REDUCING ACNE AND ROSACEA RELAPSE RATE AND SEVERITY
#177Process for preparing powders by spray drying and powders obtainable thereby
#178Free Polyunsaturated Fatty Acid-Containing Compositions and Manufacturing Method Therefor
#179SELF-EMULSIFYING COMPOSITION OF OMEGA-3 FATTY ACID
#180Compositions and methods for treating endocrine diseases and disorders
#181DHA Enriched Polyunsaturated Fatty Acid Compositions
#182LIQUID FOOD PRODUCT TO MANAGE THE KETOGENIC DIET
#183ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS
#184ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS
#185COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE
#186DIHOMO-GAMMA LINOLENIC ACID (DGLA) IS A NOVEL SENOLYTIC
#187ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS
#188ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS
#189ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS
#190COMPOSITIONS AND METHODS FOR IMPROVING CARDIOVASCULAR HEALTH
#191TOPICAL CYCLOSPORINE-CONTAINING FORMULATIONS AND USES THEREOF
#192CANCER-KILLING CELLS
#193BIOEFFECTIVE KRILL OIL COMPOSITIONS
#194WELLBEING SUPPLEMENT FOR POSTPARTUM MATERNAL NUTRITION
#195SOFT CANDY WITHOUT FISHY TASTE OR ODOR AND PREPARATION METHOD THEREOF
#196NUTRITIONAL COMPOSITION FOR IMPROVING CELL MEMBRANES
#197COMPOSITIONS COMPRISING EPA AND METHODS OF USING THE SAME FOR TREATING AND/OR PREVENTING ENDOTHELIAL DYSFUNCTION IN A SUBJECT
#198METHODS FOR TREATING DYSGEUSIA AND OTHER LINGERING SYMPTOMS ASSOCIATED WITH SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 INFECTIONADN CORONAVIRUS DISEASE 2019
#199LYMPH-RELEASING COMPOSITIONS OF FATTY ACIDS AND USES THEREOF FOR LYMPHATIC INCORPORATION AND SYSTEMIC DISEASE TREATMENT
#200Phospholipid compositions for delivery of therapeutic compounds
#201FATTY ACID DERIVATIVES FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS
#202ENTERAL FEEDING DEVICES AND RELATED METHODS OF USE
#203Pre And Post Natal Compositions Including Carotenoids
#204Method for supporting memory function and/or cognitive function
#205STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME
#206METHOD FOR REGULATING DOWNSTREAM SIGNALING PATHWAY MEDIATED BY ACTIVATION OF TRIMETHYLAMINE-N-OXIDE
#207METHODS AND COMPOSITIONS FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE
#208COMPOSITION FOR PREVENTING OR TREATING CEREBROVASCULAR DISEASE
#209COMPOSITION OF AND METHOD FOR TREATING INJURY AND/OR SKIN CONDITIONS
#210IONIC LIQUID FORMULATIONS FOR TREATING DIABETES
#211DHA Enriched Polyunsaturated Fatty Acid Compositions
#212LIQUID FOOD PRODUCT TO MANAGE THE KETOGENIC DIET
#213METHODS FOR PROVIDING HEALTH BENEFITS IN ANIMALS
#214ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS
#215Botanical formulations
#216LIPID COMPOSITIONS AND METHODS OF PREPARATION THEREOF
#217ALGAL BOTANICAL EXTRACTS RICH IN EICOSAPENTAENOIC ACID AS TRI/DIGLYCERIDE CONJUGATE
#218Methods for Assessing a Patient's Response to Treatment of a Neurodegenerative Disease with Deuterated Arachidonic Acid
#219Dosing Protocols for Administering Deuterated Arachidonic Acid or a Prodrug Thereof
#220PHARMACEUTICAL COMPOSITIONS OF D10-DOCOSAHEXAENOIC ACID OR ESTERS THEREOF
#221DELIVERY METHODS FOR OMEGA-3'S AND COMPOSITIONS FOR VITAMINS AND MINERALS USED TO ENHANCE VISUAL ACUITY AND MENTAL DEVELOPMENT IN THE HUMAN BODY
#222THRAUSTOCHYTRIDS, FATTY ACID COMPOSITIONS, AND METHODS OF MAKING AND USES THEREOF
#223VERY-LONG-CHAIN POLYUNSATURATED FATTY ACIDS, ELOVANOID HYDROXYLATED DERIVATIVES, AND METHODS OF USE
#224TREATMENT OR PREVENTION OF SURGERY-INDUCED CACHEXIA AND/OR EXPRESSION OF MYELOID-DERIVED SUPPRESSOR CELLS AND PRO-INFLAMMATORY CYTOKINES
#225Methods, compositions, and devices for supplying dietary fatty acid needs
#226PHARMACEUTICAL COMPOSITION FOR TREATING CHRONIC KIDNEY DISEASE
#227Nutritional Formulas Comprising Medium Chain Fatty Acids or Esters Thereof and Methods Related Thereto
#228BOTANICAL FORMULATIONS
#229PRECISION CANNABINOID THERAPY FORMULATIONS AND METHODS OF USE
#230COMPOSITIONS AND METHODS FOR NEUROPROTECTION IN NEONATAL HYPOXIC-ISCHEMIC ENCEPHALOPATHY
#231OMEGA-3 FATTY ACID AND VITAMIN D LEVELS TO IDENTIFY AND ATTENUATE COGNITIVE AGING IN INDIVIDUALS
#232METHODS AND COMPOSITIONS FOR TREATING EYE DISEASES
#233VERY-LONG-CHAIN POLYUNSATURATED FATTY ACIDS, ELOVANOID HYDROXYLATED DERIVATIVES, AND METHODS OF USE
#234ROSA CANINA ROSEHIP
#235COMPOSITION AND FUNCTIONAL FOOD FOR PREVENTING MYOPIA
#236COMPOSITION FOR EXTERNAL USE ON SKIN FOR INFLAMMATORY DISEASES
#237MICROBIOME MEDIATED INDUCTION OF IMMUNE TOLERANCE AND RESOLUTION OF INFLAMMATION
#238METHODS OF TREATING HYPERTRIGLYCERIDEMIA
#239PHARMACEUTICAL COMPOSITION COMPRISING EICOSAPENTAENOIC ACID AND NICOTINIC ACID AND METHODS OF USING SAME
#240OIL-IN-WATER EMULSIFIED COMPOSITION
#241PHARMACEUTICAL COMPOSITION COMPRISING EICOSAPENTAENOIC ACID AND DERIVATIVES THEREOF AND A STATIN
#242COMPOSITION FOR ENHANCING ADRENOMEDULLIN GENE EXPRESSION
#243OMEGA-3 POLYUNSATURATED FATTY ACIDS FOR TREATING / PREVENTING MALE INFERTILITY IN PREPUBERTAL CANDIDATES FOR GONADOTOXIC THERAPIES
#244COMPOSITION FOR USE IN TREATMENT OF A BIOFILM IN A SUBJECT
#245LIPID COMPOSITIONS COMPRISING TRIACYLGLYCEROL WITH LONG-CHAIN POLYUNSATURATED FATTY ACIDS
#246ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS
#247Disorders implicating PUFA oxidation
#248TOPICAL FORMULATION COMPRISING OMEGA-3 FATTY ACIDS, MELATONIN AND VITAMIN D
#249Lipid Prophylactic Brain Injury Treatment
#250Pet Food Compositions
#251Pet Food Compositions
#252Use of Milk Fat Globule Membrane
#253FORMULATIONS CONTAINING OMEGA-3 FATTY ACIDS OR ESTERS THEREOF AND MAQUI BERRY EXTRACT AND THERAPEUTIC USES THEREOF
#254Bag System Containing a Nutrient Composition Comprising Whole Food Sole Source Meal
#255MODULATION OF BETA CELL REGENERATION THROUGH GPR75 SIGNALING
#256METHODS FOR STABILIZING ATHEROSCLEROTIC PLAQUES USING LIPOXINS, RESOLVINS, AND ANALOGS THEREOF
#257LIPID COMPRISING DOCOSAPENTAENOIC
#258CANCER-KILLING CELLS
#259ORAL FORMULATIONS OF BIPOLAR TRANS CAROTENOIDS
#260ADMINISTRATION OF R-BETA-HYDROXYBUTYRATE AND RELATED COMPOUNDS IN VETERINARY APPLICATIONS
#261Methods and compositions with purified cocoon silk peptide fiber and refined seed oil providing anti-inflammatory effects and neuroprotection for disease states
#262PROCESSES FOR PRODUCING LOW CHLOROPHYLL, HIGH POLAR LIPID COMPOSITIONS FROM ALGAL OILS AND EXTRACTS
#263COMPOSITIONS COMPRISING MONO- AND DI-GLYCERIDES WITH OMEGA-3 FATTY ACYL GROUPS AND METHODS OF USING SAME
#264COMBINATION COMPOSITIONS AND METHODS FOR TREATING CANCER
#265ANTIMICROBIAL COMPOSITIONS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF
#266SEMIFLUORINATED ALKANE COMPOSITIONS
#267COMPOSITION OF ACTIVE AGENTS TO POSITIVELY AFFECT A ROBUST MAMMALIAN ENDOCANNABINOID SYSTEM TONE TO BETTER ADDRESS AGE RELATED DISCOMFORT
#268FOOD SUPPLEMENT AND FOOD
#269APPLICATION OF REGULATION OF EYE SCLERA LIPID METABOLISM TO INHIBIT MYOPIA
#270COMPOSITIONS AND METHODS THAT ATTENUATE COGNITIVE AGING IN INDIVIDUALS WHO DO NOT HAVE DEMENTIA
#271INTELLIGENT DELIVERY OF INGESTED AND ABSORBED MOLECULES
#272Methods for treating neurological disorders using nutrient compositions
#273METHODS AND COMPOSITIONS FOR TREATMENT OF INFLAMMATORY DISEASE
#274Product and method for increasing uridine concentration in blood plasma
#275Combination methods and compositions including sleep therapeutics for treating mood
#276Specialized pro-resolving mediators (SPMs) as melanocyte growth promoter and pro-survival factors and uses thereof
#277TRANS-CROCETIN COMPOSITIONS AND TREATMENT REGIMENS
#278NOBILETIN COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF COVID-19 AND RELATED PATHOLOGIES
#279TRANS-CROCETIN COMPOSITIONS AND TREATMENT REGIMENS
#280METHOD OF INCREASING THE POPULATION OF DIALISTER SPP. IN THE GUT MICROBIOME
#281COMPOSITIONS COMPRISING QUILLAJA EXTRACT AND METHODS OF PREPARATIONS AND USE THEREOF
#282NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF
#283METHODS OF TREATING AMYOTROPHIC LATERAL SCLEROSIS
#284CANNABINOID AND OMEGA FATTY ACID COMPOSITIONS AND METHODS OF USING
#285ISOTONIC LIPID EMULSION
#286METHODS FOR INHIBITING THE PROGRESSION OF NEURODEGENERATIVE DISEASES
#287METHODS FOR IDENTIFYING PRE-DISPOSITION TO COGNITIVE DECLINE AND AGENTS FOR REDUCING OR PREVENTING COGNITIVE DECLINE, OR IMPROVING COGNITIVE ABILITY
#288RETINAL BIOAVAILBILITY OF SYNTHETIC VERY-LONG-CHAIN POLYUNSATURATED FATTY ACIDS
#289METHODS AND COMPOSITIONS FOR TREATMENT OF AGE-RELATED MACULAR DEGENERATION
#290LIPID COMPRISING DOCOSAPENTAENOIC
#291COMPOSITION AND METHOD FOR OMEGA-3 AND PLANT FLAVONOIDS FOR INCREASING HDL CHOLESTEROL AND DECREASING LDL CHOLESTEROL AND TRIGLYCERIDE LEVELS
#292COMBINATION THERAPY USING ENANTIOPURE, OXY-SUBSTITUTED, DEUTERIUM-ENRICHED 5-(BENZYL)-5-DEUTERO-THIAZOLIDINE-2,4-DIONES FOR TREATMENT OF MEDICAL DISORDERS
#293COMPOSITIONS COMPRISING A FATTY ACID OIL MIXTURE AND A SURFACTANT, AND METHODS AND USES THEREOF
#294A FATTY ACID BASED COMPOSITION FOR TREATMENT AND/OR PREVENTION OF ENVELOPED-VIRUS RELATED INFECTIONS
#295COMPOSITIONS AND METHODS FOR TREATING DEPRESSION
#296COMPOSITIONS AND METHODS THAT MODULATE VITAMIN D AND BONE MINERAL CONTENT IN A COMPANION ANIMAL
#297Compositions and methods for lowering triglycerides
#298TRANS-CROCETIN COMPOSITIONS AND TREATMENT REGIMENS
#299COMPOSITION FOR RELIEVING HANGOVER AND IMPROVING LIVER FUNCTION
#300COMPOSITIONS FOR IMPROVING EYE HEALTH AND METHODS OF MAKING AND USING THEREOF